Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis

Sana Niazi1, Farideh Doroodgar1, Saeed Hashemi Nazari2

  • 1Negah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Translational Ophthalmology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

PubMed

Insights

For progressive keratoconus (KC), combining treatments like phakic intraocular lenses, intracorneal ring segments (ICRS), and corneal cross-linking (CXL) offers optimal outcomes. This network meta-analysis guides surgical planning for improved visual acuity.

Area of Science:

  • Ophthalmology
  • Corneal Surgery
  • Vision Science

Background:

  • Keratoconus (KC) management has evolved with advanced diagnostics and less invasive treatments.
  • Effective KC treatment planning requires integrating clinical science, evidence, and surgical skill.
  • Assessing disease progression is vital, with halting progression being a primary goal.

Purpose of the Study:

  • To conduct a network meta-analysis comparing combined refractive treatments for keratoconus (KC).
  • To evaluate the effectiveness of various treatment combinations across different follow-up periods.
  • To provide evidence-based guidance for selecting optimal KC surgical approaches.

Main Methods:

  • Comprehensive network meta-analysis of combined therapeutic refractive treatments for KC.
  • Comparison of treatments across identical disease stages and 4 distinct follow-up intervals.
  • Analysis focused on visual acuity and other primary factors influencing treatment selection.

Main Results:

  • For regular corneas (optimal preoperative BCVA) up to stage 3, combining phakic intraocular lenses with ICRS and CXL shows promise.
  • For irregular corneas, initial surface ablation benefits BCVA, but long-term results favor combining it with ICRS and CXL, especially in advanced stages.

Conclusions:

  • Surgical planning for KC should be tailored to individual patient conditions and disease stages.
  • Combined therapies, particularly ICRS and CXL, are recommended for progressive KC, with specific combinations depending on corneal regularity and disease severity.
  • This analysis aids surgeons in choosing appropriate treatments for optimal patient outcomes in keratoconus.